Cyber​​kinetics

Cyber​​kinetics, Inc. is a neurotechnology company commercializing brain-computer interfaces. BrainGate's mission is to further advance the development of this life-changing technology to promote broader adoption to help impaired individuals communicate and interact with society. For instance, the Cyber​​kenetics BrainGate neural interface is currently the subject of an experimental clinical trial under the FDA’s Investigational Device Exemption (IDE). The system aims to restore function for individuals with severe motor impairments who have limited or no ability to move.